Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B

Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B

US Patent 5532246 · Granted Jul 2, 1996

Estimated economic value: $24,337,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for the treatment or prevention of Flavivirus infections2014
Compounds and methods for the treatment or prevention of flavivirus infections2013
Compounds and methods for the treatment or prevention of Flavivirus infections2012
Compounds and methods for the treatment or prevention of Flavivirus infections2008
Acetaldehyde acetal compounds, their synthesis, and uses thereof2006
Acetaldehyde acetal compounds, their synthesis, and uses thereof2006
Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral prope2006
Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B2006
Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B2006
Compounds and methods for the treatment or prevention of flavivirus infections2005
Substituted 1,3-oxathiolanes2005
Substituted 1,3-oxathiolanes2005